Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal.

Dr. Harry A. Quigley is the A. Edward Maumenee Professor of Ophthalmology and developed the Glaucoma Division at the Johns Hopkins Wilmer Eye Institute. He was a founding member of the American Glaucoma Society, serving for 8 years as its Secretary and was elected to 5 year terms as chief executive officer of the Association for Research in Vision and Ophthalmology (ARVO) and editor-in-chief of Investigative Ophthalmology and Visual Science. He has published over 350 peer-reviewed articles, and his reports are the most cited in the ophthalmic literature over the last 30 years (Archives of Ophthalmology, 2007). His research has improved the early diagnosis of glaucoma and has developed instruments and techniques to identify glaucoma damage better. He has participated in pioneering studies of the epidemiology, morbidity and progression rate of glaucoma and other eye disease in American, African, Asian and Hispanic populations, serving as a consultant to the World Health Organization. In the laboratory, he has demonstrated successful gene therapy to protect retinal ganglion cells from experimental glaucoma and developed glaucoma models in monkeys, rats and mice. Dr. Quigley is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

Alan Robin is an Ophthalmologist in Baltimore, Maryland. Dr. Robin is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Cataract Removal, and Trabeculectomy.

Jacob Kanter, M.D., is a cataract and glaucoma surgeon practicing at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Kanter is a glaucoma specialist who focuses on the diagnosis, treatment and management of all forms of open angle and angle-closure glaucoma. He performs cataract surgery and glaucoma surgery, including both the latest micro invasive glaucoma surgeries (MIGS) and traditional glaucoma surgeries. He also performs clinic-based procedures including selective laser trabeculoplasty (SLT), YAG laser capsulotomy and laser peripheral iridotomy. Dr. Kanter is involved with several clinical trials investigating the latest glaucoma surgeries. He is also researching the role of home tonometry in glaucoma care, which can uncover intraocular pressure fluctuations outside the office and help elucidate how glaucoma progresses. He has a special interest in improving patient-doctor communication, streamlining patients’ experiences with glaucoma surgery, and medical education. Dr. Kanter is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Retinal Vein Occlusion, and Trabeculectomy.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.

Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Cindy X. Cai, M.D., is the Jonathan and Marcia Javitt Rising Professor of Ophthalmology and a retina specialist seeing patients at the Wilmer Eye Institute’s locations in the Baltimore, Maryland area. Her primary focuses are in medical and surgical retina treatments, including: diabetic retinopathy, diabetic macular edema, age-related macular degeneration, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane, and macular hole, among others. Dr. Cai graduated summa cum laude with a major in biology at Columbia University and received her M.D. from the Columbia University College of Physicians and Surgeons in New York. She completed her medical internship at Mercy Medical Center in Baltimore and her ophthalmology residency training at the Wilmer Eye Institute. She received her vitreoretinal surgery fellowship training at Duke Eye Center. Videos Dr. Cindy X. CaiOphthalmologist and Retina Specialist Recent News Articles and Media Coverage Continuing the Mission, Johns Hopkins Medicine (Dec. 2021) Get to Know Cindy Cai, Wilmer Insider (Apr. 2021). Dr. Cai is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). Her top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Gyrate Atrophy of the Choroid and Retina, Vitrectomy, and Cataract Removal.

Bryce Chiang, M.D., Ph.D., is an assistant professor of ophthalmology and a glaucoma specialist at the Wilmer Eye Institute, Johns Hopkins Medicine East Baltimore location. His clinical interests include the medical and surgical management of glaucoma and cataract. After receiving his combined bachelor’s/master’s degrees in biomedical engineering from The Johns Hopkins University, Dr. Chiang completed joint M.D./Ph.D. degrees at the Emory University School of Medicine. During his doctorate in biomedical engineering at the Georgia Institute of Technology, Dr. Chiang became interested in ophthalmology through his research in ocular drug delivery. He served as a medicine intern at Highland Hospital in Oakland, California, and completed his ophthalmology residency, glaucoma fellowship and innovation fellowship at the Byers Eye Institute at Stanford University. Dr. Chiang’s research interests include targeted ocular drug delivery, specifically within the suprachoroidal space and to the optic nerve head. He studied the pharmacokinetics of microneedle injections into the suprachoroidal space while pursuing his doctorate at Georgia Tech, and maintains an interest in the suprachoroidal space as a means of altering disease trajectory. Furthermore, despite the optic nerve head being the site of disease in optic neuropathies, no therapies exist that treat the optic nerve head. By directly treating the diseased tissue, targeting therapeutics to the optic nerve head may enable paradigm shifting therapies for optic neuropathies. Targeted delivery to the optic nerve head may also serve as a research tool to query the pathogenesis of glaucoma. Dr. Chiang is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Uveitis, and Nearsightedness.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Daniel Rhee, M.D., M.P.H., joins the Johns Hopkins Department of Surgery as Assistant Professor of Surgery and Director of the Pediatric Surgical Oncology Program. Dr. Rhee’s areas of clinical expertise include pediatric surgical oncology as well as neonatal and general pediatric surgery. Dr. Rhee received his undergraduate degree from the University of Michigan and earned his medical degree from The Ohio State University College of Medicine. He completed his residency in general surgery at St. Joseph Mercy Hospital before completing fellowships at Johns Hopkins Hospital in Pediatric Surgery and Memorial Sloan Kettering Cancer Center in Pediatric Surgical Oncology. Dr. Rhee is a member of several professional societies, including the American College of Surgeons, American Pediatric Surgical Association, the Association of Academic Surgeons, the Children’s Oncology Group, and The International Society of Paediatric Surgical Oncology. Dr. Rhee’s research interests involve childhood tumors including neuroblastoma, sarcoma, Wilms tumor, hepatoblastoma, pancreatoblastoma, reconstruction for chest wall tumors, germ cell tumors, and desmoplastic small round cell tumors. His research interests also include use of 3D printing for simulation for surgical training, improving surgical outcomes in pediatric surgery and improving access to surgical care in low and middle-income countries. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Adult Soft Tissue Sarcoma, Appendicitis, Tracheoesophageal Fistula, Appendectomy, and Pancreaticoduodenectomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Robert Loeb is an Ophthalmologist in Baltimore, Maryland. Dr. Loeb is rated as a Distinguished provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Cataract, and Eyelid Bump. Dr. Loeb is currently accepting new patients.

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Nakul Shekhawat, M.D., M.P.H. is an ophthalmologist and eye surgeon at the Johns Hopkins Wilmer Eye Institute and the 2023 Stephen F Raab and Mariellen Brickley-Raab Rising Professor of Ophthalmology. He specializes in cataract surgery, complex cataract and anterior segment surgery, corneal and external diseases, and corneal surgery including both full- and partial-thickness corneal transplantation (DMEK, DSAEK, DALK, PKP). Dr. Shekhawat received his M.D. degree from Vanderbilt University School of Medicine and his M.P.H. degree in epidemiology and biostatistics from the Johns Hopkins Bloomberg School of Public Health. He completed ophthalmology residency at the renowned Kellogg Eye Center, University of Michigan where he received the Resident Excellence Award from the American Society of Cataract and Refractive Surgery. He completed additional subspecialty training in cornea, external disease, and refractive surgery at the Wilmer Eye Institute where he was awarded the prestigious Claes Dohlman Award from Harvard Medical School recognizing the most outstanding cornea fellow in the country. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Shekhawat_CV.pdf Recent News Articles and Media Coverage Laser cataract surgery now offered in Bethesda- Hopkins Medicine (April 2024) Johns Hopkins, Microsoft Extend Collaboration for Startups as Newest Grant Recipients Named - Johns Hopkins Technology Ventures (July 2021) Taking a Wide View with Nakul Shekhawat - Hopkins Medicine (September 2020) A Patient’s Guide to Shingles: Prompt treatment is crucial to avoid severe neurological complications - US News & World Report (January 2020) Shingle White Female: Study finds three-fold increase in number of Americans diagnosed with shingles - The Ophthalmologist (July 2019). Dr. Shekhawat is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Interstitial Keratitis, Cataract, Amebiasis, Cataract Removal, and Vitrectomy.

Jennifer Thorne, M.D., Ph.D., is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, where she is also chief of the Division of Ocular Immunology. Dr. Thorne holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. An internationally recognized ophthalmologist, Dr. Thorne is an expert in the evaluation and management of patients with uveitis and other related immune-mediated disorders. Dr. Thorne also directs the Mucous Membrane Pemphigoid clinic, a multi-disciplinary specialty clinic designed to evaluate and treat patients with conjunctival diseases. Dr. Thorne's research interests include white dot syndromes including birdshot chorioretinitis, multifocal choroiditis and punctate inner choroiditis. She also studies juvenile idiopathic arthritis-related uveitis and treatment outcomes of immunosuppressive drug therapy. Dr. Thorne received her M.D. degree from the University of Virginia and completed her ophthalmology residency at the University of Pennsylvania's Scheie Eye Institute. She completed her uveitis fellowship at Wilmer and completed her Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Thorne is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). Her top areas of expertise are Uveitis, Neuroretinitis, Punctate Inner Choroidopathy, and Cicatricial Pemphigoid.

Michael Sulewski, M.D., is the James and Heather Gills Rising Professor of Ophthalmology and a cornea and cataract specialist at the Wilmer Eye Institute’s Baltimore locations at Bayview Medical Center and the Patient Access Center for the Eye at The Johns Hopkins Hospital, as well as in White Marsh, Maryland. Dr. Sulewski is also the ophthalmology residency program director. Dr. Sulewski specializes in cataract surgery, intraocular lens complications, corneal transplantation, keratoprosthesis, refractive surgery and other medical and surgical diseases of the cornea and anterior segment of the eye. Dr. Sulewski is also a resident supervisor at the Wilmer Eye Institute Patient Center for the Eye at The Johns Hopkins Hospital. Recent News Articles and Media Coverage Five Questions for Michael Sulewski, Johns Hopkins Medicine (Dec. 2020). Dr. Sulewski is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Cataract, Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE), Cogan's Syndrome, Interstitial Keratitis, and Cataract Removal.

Nur Cardakli is an Ophthalmologist in Baltimore, Maryland. Dr. Cardakli is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Esotropia, Pigment-Dispersion Syndrome, and Trabeculectomy.